Literature DB >> 10065146

[Organ preservation in bladder carcinoma by chemotherapy and TUR].

J Dunst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10065146     DOI： 10.1007/bf02753850

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  4 in total

1.  Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.

Authors:  H W Herr; D F Bajorin; H I Scher
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

2.  Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.

Authors:  M Housset; C Maulard; Y Chretien; B Dufour; S Delanian; J Huart; F Colardelle; P Brunel; F Baillet
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

3.  Organ-sparing treatment of advanced bladder cancer: a 10-year experience.

Authors:  J Dunst; R Sauer; K M Schrott; R Kühn; C Wittekind; A Altendorf-Hofmann
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-09-30       Impact factor: 7.038

4.  A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.

Authors:  A L Zietman; W U Shipley; D S Kaufman; E M Zehr; N M Heney; A F Althausen; F J McGovern
Journal:  J Urol       Date:  1998-11       Impact factor: 7.450
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.